A Study to Assess the Safety, Pharmacokinetics and Anti Tumor Activity of UCB6114 Administered Intravenously to Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to mFOLFOX6
Related studies linked through entity extraction aliases.
CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II
- Status
- RECRUITING
- Phase
- PHASE3
Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC
- Status
- TERMINATED
- Phase
- PHASE2
Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
PDR001 in Combination With Bevacizumab and mFOLFOX6 as First Line Therapy in Patients With Metastatic MSS Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Induction Chemotherapy for Locally Advanced Esophageal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
IV Ascorbic Acid in Advanced Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Cetuximab Monotherapy Maintenance Treatment in mCRC
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Cetuximab Maintenance Treatment Versus Continuation After Induction Therapy in mCRC
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
FOLFOX6 Totally Neoadjuvant Chemoradiation Therapy in Locally Advanced Rectal Cancer: A Real World Study
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Alternative Dosing for CRLX101(NLG207) Alone, With Avastin and With mFOLFOX6 in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Adjuvant Chemotherapy Based on the Adenosine Triphosphate Tumor Chemosensitivity Assay for Hepatocellular Carcinoma After Liver Transplantation
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
- Status
- COMPLETED
- Phase
- PHASE3
Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Postoperative Hepatic Arterial Chemotherapy in High-risk Patients as Adjuvant Treatment After Resection of Colorectal Liver Metastases
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Adults With Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Study of Pembrolizumab in Combination With Chemotherapy for Patients With Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2